JENNIFER LITTLEFIELD: Open Payments
NPI 1770835670 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 21 payments from 10 companies in 2025. Trend: 2023 $712 · 2024 $524 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| ABBVIE INC. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $39 |
| Lilly USA, LLC | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
Products named: UBRELVY, ELIQUIS, BREZTRI, Veozah, Kerendia, Cologuard Collection Kit, MOUNJARO, JARDIANCE.
Industry payments across MI — which companies pay providers there.
